Text size Data from BioNTech and Pfizer were particularly promising. Jeenah Moon / Getty Images After a hiatus from a late summer break, the news of a Covid-19 vaccine is heating up again as a handful of leading programs are rapidly moving to a decisive phase. Reports from several companies …
Read More »
Johnson & Johnson plans to launch in late September what may be the largest clinical trial to date against a coronavirus vaccine, enrolling up to 60,000 people worldwide to test whether the experimental shot safely protects against Covid-19. The targeted enrollment, reported on a government database and confirmed by the …
Read More »
Text size The Food and Drug Administration on Tuesday rejected Gilead Science’s application for a will-be blockbuster arthritis medicine, blind investors. One analyst called the development a ‘near-worst-case scenario’ and a ‘shock’. Dreamstime The Food and Drug Administration’s decision to deny Gilead Science’s application for a wild medicine for blockbuster …
Read More »
Text size Andrey Rudakov / Bloomberg Novavax said it has a deal with SK Bioscience to produce the antigen component of its Covid-19 vaccine candidate during the pandemic period. The stock jumped more than 9% Thursday morning. Novavax (ticker: NVAX) said its development and supply agreement with the South Korean …
Read More »
Text size Johnson & Johnson became the third western biopharmaceutical company to start a new test of its Covid-19 vaccine this week, but with one difference: in a surprise announcement Thursday morning, the company said it would test its vaccine in a format single dose. Moderna (MRNA) and Pfizer (PFE) …
Read More »